Brain MRI results of DECIDE: a randomized, double-blind trial of DAC HYP vs. IFNβ-1a in RRMS patients

被引：0
|
作者：
Arnold, D. L. [1 ,2 ]
Kappos, L. [3 ]
Havrdova, E. [4 ]
Selmaj, K. [5 ]
Boyko, A. [6 ]
Kaufman, M. [7 ]
Wiendl, H. [8 ]
Rose, J. [9 ]
Greenberg, S. [10 ]
Demirhan, E. [11 ]
Sweetser, M. [11 ]
Riester, K. [11 ]
Elkins, J. [11 ]
机构：
[1] NeuroRx Res, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Charles Univ Prague, Sch Med 1, Prague, Czech Republic
[5] Med Univ Lodz, Lodz, Poland
[6] Moscow Multiple Sclerosis Ctr, Moscow, Russia
[7] Carolinas Med Ctr, Charlotte, NC 28203 USA
[8] Univ Munster, D-48149 Munster, Germany
[9] Univ Utah, Sch Med, Salt Lake City, UT USA
[10] Abbvie Biotherapeut Inc, Redwood City, CA USA
[11] Biogen Idec Inc, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P051
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
    Kappos, L.
    Selmaj, K.
    Arnold, D. L.
    Havrdova, E.
    Boyko, A.
    Kaufman, M.
    Wiendl, H.
    Rose, J.
    Greenberg, S.
    Demirhan, E.
    Sweetser, M.
    Riester, K.
    Elkins, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 38 - 38
  • [2] Cinnovex vs. Avonex: a double-blind, randomized, non-inferiority trial, preliminary results
    Nafissi, Shahriar
    Azimi, Amir Reza
    Majidzadeh, Keivan
    Mahboudi, Fereidoun
    MULTIPLE SCLEROSIS, 2008, 14 : S168 - S168
  • [3] Effects of ziprasidone on cognitive function in patients with schizophrenia: Results of a double-blind trial vs. olanzapine
    Harvey, PD
    Simpson, G
    Horne, R
    Weiden, PJ
    Bari, M
    Romano, SJ
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 195 - 195
  • [4] Electrobrasion vs. manual dermabrasion: a randomized, double-blind, comparative effectiveness trial
    Kleinerman, R.
    Armstrong, A. W.
    Ibrahimi, O. A.
    King, T. H.
    Eisen, D. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 124 - 129
  • [5] Daclizumab High-Yield Process (DAC HYP) vs. Interferon beta-1a in patients with highly active disease: DECIDE study results
    Wiendl, H.
    Kappos, L.
    Selmaj, K.
    Havrdova, E.
    Rose, J.
    Riester, K.
    Tsao, L. C.
    Greenberg, S.
    Elkins, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 50 - 50
  • [6] Donepezil vs. propranolol for migraine prevention: Results of a randomized, controlled, double-blind, double-dummy clinical trial
    Klapper, J
    Mathew, NT
    Abu-Shakra, S
    NEUROLOGY, 2005, 64 (06) : A335 - A335
  • [7] Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal
    Akhondzadeh, S
    Ahmadi-Abhari, SA
    Assadi, SM
    Shabestari, OL
    Kashani, AR
    Farzanehgan, ZM
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2000, 25 (05) : 347 - 353
  • [8] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [9] A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma
    Espinal-Perez, LE
    Moncada, B
    Castanedo-Cazares, JP
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (08) : 604 - 607
  • [10] A double-blind randomized clinical trial of gabapentin vs. placebo for treating alcohol dependence
    Brower, KJ
    Kim, HM
    Karam-Hage, MA
    Zucker, RA
    Greden, JF
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 84S - 85S
12345